Home
/
AVITA Medical, Inc.
/
Financials
/
Quarterly
AVITA Medical, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that AVITA Medical, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$17.06M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$18.42M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$18.51M
May 8, 2025
Q3
2025
Sep 30, 2024
$19.55M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$15.20M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$11.10M
May 8, 2025
Q3
2024
Sep 30, 2023
$13.65M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$11.75M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$10.55M
May 13, 2024
Q3
2023
Sep 30, 2022
$9.09M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$8.34M
Aug 10, 2023
Q1
2023
Mar 31, 2022
$7.54M
May 11, 2023
Q1
2022
Sep 30, 2021
$7.02M
Nov 8, 2021
Q3
2022
Sep 30, 2021
$7.02M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$10.30M
Aug 11, 2022
Q3
2021
Mar 31, 2021
$8.77M
May 13, 2021
Q1
2022
Mar 31, 2021
$8.77M
May 12, 2022
Q2
2021
Dec 31, 2020
$5.10M
Feb 16, 2021
Q1
2022
Sep 30, 2020
$5.06M
Nov 8, 2021
Q3
2021
Mar 31, 2020
$3.88M
May 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($13.19M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($9.92M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($13.86M)
May 8, 2025
Q3
2025
Sep 30, 2024
($16.21M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($15.39M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($18.66M)
May 8, 2025
Q3
2024
Sep 30, 2023
($8.71M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($10.38M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($9.22M)
May 13, 2024
Q3
2023
Sep 30, 2022
($5.59M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($6.26M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($9.46M)
May 11, 2023
Q3
2022
Sep 30, 2021
($5.95M)
Nov 10, 2022
Q1
2022
Sep 30, 2021
($5.95M)
Nov 8, 2021
Q2
2022
Jun 30, 2021
($4.72M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($6.00M)
May 12, 2022
Q3
2021
Mar 31, 2021
($6.00M)
May 13, 2021
Q2
2021
Dec 31, 2020
($5.64M)
Feb 16, 2021
Q1
2022
Sep 30, 2020
($10.23M)
Nov 8, 2021
Q3
2021
Mar 31, 2020
($15.05M)
May 13, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($9.15M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($11.15M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($11.83M)
May 8, 2025
Q3
2025
Sep 30, 2024
($13.81M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($15.62M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($17.21M)
May 8, 2025
Q3
2024
Sep 30, 2023
($9.31M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($11.17M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($9.91M)
May 13, 2024
Q3
2023
Sep 30, 2022
($5.75M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($6.36M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($9.49M)
May 11, 2023
Q3
2022
Sep 30, 2021
($5.95M)
Nov 10, 2022
Q1
2022
Sep 30, 2021
($5.95M)
Nov 8, 2021
Q2
2022
Jun 30, 2021
($4.70M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($5.99M)
May 12, 2022
Q3
2021
Mar 31, 2021
($5.99M)
May 13, 2021
Q2
2021
Dec 31, 2020
($5.63M)
Feb 16, 2021
Q1
2022
Sep 30, 2020
($10.21M)
Nov 8, 2021
Q3
2021
Mar 31, 2020
($15.41M)
May 13, 2021